Bio-Rad Laboratories, Inc. Class A Common Stock vs Nucor Corporation — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Nucor Corporation trades at $271.95 (market cap $61.93B). The key difference: Nucor Corporation is far larger — about 6.6× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Nucor Corporation pays a 0.82% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | NUE | |
|---|---|---|
Market Cap | $9.43B | $61.93B |
Sector | Health | Basic Materials |
52-Week High | $356.25 | $274.74 |
52-Week Low | $241.71 | $131.78 |
Enterprise Value | $9.18B | $66.34B |
Dividend Yield | — | 0.82% |
Trailing returns across standard periods
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →